The tumor-promoting RBM4-S variant is produced in lung cancer cells via the m6A-YTHDC1 complex, which facilitates exon3 skipping of RBM4 mRNA by attracting AURKA-mediated hnRNPK [63]. The gene discussed is RBM4; the disease is lung carcinoma.